Amgen Inc (AMGN)
$460.42 $0.96 (0.21%) 4:36 PM 11/06/2026
NASDAQ | $USD | Drug Manufacturers - GeneralStock Data
-
Market Cap
$251.94B -
Day's Range
$447.04 - $462.91 -
Volume
2,846,609 -
52 Week Low / High
$288.00 - $475.65 -
PE Ratio
28.94x -
PEG Ratio
- -
Dividend Frequency
quarterly
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyst ratings: Buy 12, Hold 17, Sell 5.
Company News
-
Amgen (AMGN) Takes Aim At Rare Disease Delays While Expanding RNA Drug Hunt — Nov 5, 2026
Amgen (NasdaqGS:AMGN) announced a new collaboration with the National Organization for Rare Disorders to speed rare autoimmune disease diagnosis. The partners are targeting a goal to cut average diagnosis times for selected rare autoimmune conditions by 2036 through data and education effo...
-
REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY — Nov 5, 2026
Findings Represent Largest and Most Rigorous Head-to-Head Real-World Outcomes Analysis of Repatha and Ezetimibe Study Examined More Than Half a Million Adults Living with Heart Disease Results Provide Important New Clinical Evidence to Inform Non-Statin Treatment Decisions for Patients THO...
-
Spdr Dow Jones Industrial Average ETF (DIA) Sells Goldman Sachs, Caterpillar on Nov. 3 — Nov 5, 2026
This article first appeared on GuruFocus. Spdr Dow Jones Industrial Average ETF Trust (DIA) generated $310.2 million in ETF activity on Tuesday, all of it on the sell side. The $44.89 billion fund bought no shares, increased no positions and reduced all 30 of its holdings, leaving net boug...
-
Stocks Surged Across the Board Today, and Biotech Brought Its Own Earnings Story — Nov 4, 2026
NEW YORK, Nov. 4, 2026 /PRNewswire/ -- Fly on Wall Street News Commentary - Wall Street's major indexes rallied together on Wednesday. As of 2:31 p.m. ET, the Dow Jones Industrial Average was up 1,552.12 points, or 3.0%, at 53,338.84, while the S&P 500 was up 1.8% at 7,702.43 and the Nasda...
-
Blue Chips Surge Past 2.8% as VIX Drops Below 18 While Oil Sinks Nearly 8% — Nov 4, 2026
VANCOUVER, BC, Nov. 4, 2026 /PRNewswire/ -- Stock Preachers News Commentary - Wall Street roared higher this week, with the Dow jumping 2.87% in a single session to a record 53,275.11 and the S&P 500 and Nasdaq both posting strong single-day gains above 1.7%. Volatility eased sharply, with...
-
Amgen earnings analysis: questions answered and next catalysts — Nov 4, 2026
Investing.com -- Amgen Inc (AMGN) reported Q3 on Nov 3, 2026, and the numbers were strong. Adjusted EPS was $6.45 against a $5.76 estimate (+11.98%), and revenue was $10.40B against $10.06B. The stock is $478.5 (+3.74%) as of Nov 4, 12:25 PM EST, near its 52-week high of $482.0. It is up a...
-
Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test — Nov 4, 2026
This article first appeared on GuruFocus. Amgen (NASDAQ:AMGN) gave investors a reason to pay up. The biotechnology company raised its full-year outlook after Tuesday's close, and shares climbed 5.91% to $488.50 at 8:28 a.m. ET in November 4 premarket trading. The stronger forecast lifts th...
-
BC-Most Active Stocks — Nov 4, 2026
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Curis Inc. 116,764,683 1.60 1.08 1.195 +0.4811 Helport AI Ltd 105,961,211 0.338 0.2986 0.32 +0.0794 FTC Solar Inc. 65,958,0...
-
AMGN Stock Down Despite Q3 Earnings & Sales Beat, Raised Guidance — Nov 4, 2026
Amgen AMGN reported third-quarter 2026 adjusted earnings of $6.45 per share, up 14% year over year, driven primarily by higher revenues, which offset the impact of higher costs. Earnings per share beat the Zacks Consensus Estimate of $5.74. Total revenues increased 8% year over year to $10...
-
Amgen Inc (AMGN) (Q3 2026) Earnings Call Highlights: Revenue Up 8% to $10. ... — Nov 4, 2026
This article first appeared on GuruFocus. Total Revenue: Q3 2026 total revenues grew 8% year over year to $10.4 billion. Product Sales: Grew 8% year over year; six key growth drivers grew 27% and represented over 70% of Q3 product sales. Non-GAAP Operating Margin: 47% in Q3 2026; full-year...
Portfolio
Comprised of 1 portfolios



